Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Verger

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|July 10, 2014
Interferon alfa therapy in CALR-mutated essential thrombocythemiaBruno Cassinat, Emmanuelle Verger, Jean-Jacques Kiladjian
Thrombosis Research|August 19, 2015
Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasmEmmanuelle Verger, Isabelle Crassard, Bruno Cassinat, et al.
The Indian Journal of Medical Research|November 18, 2011
Pathophysiological insights in sickle cell diseaseMarie-Hélène Odièvre, Emmanuelle Verger, Ana Cristina Silva-Pinto, et al.
British Journal of Haematology|January 18, 2014
TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosisEmmanuelle Verger, Annalisa Andreoli, Christine Chomienne, et al.
Journal of Proteome Research|January 7, 2006
Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical RegionJoo-Ho Shin, Talin Gulesserian, Emmanuelle Verger, et al.
Clinical Hemorheology and Microcirculation|September 5, 2013
Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cellsEmmanuelle Verger, Damien Schoëvaërt, Pascal Carrivain, et al.
Leukemia & Lymphoma|August 27, 2016
Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN cloneEmmanuelle Verger, Ekarat Rattarittamrong, Gil Letort, et al.
British Journal of Haematology|November 17, 2015
Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutationEmmanuelle Verger, France Teillet, Carole Conejero, et al.
Haematologica|May 17, 2020
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patientsBruno Cassinat, Emmanuelle Verger, Nabih Maslah, et al.
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|July 10, 2014
Interferon alfa therapy in CALR-mutated essential thrombocythemiaBruno Cassinat, Emmanuelle Verger, Jean-Jacques Kiladjian
Thrombosis Research|August 19, 2015
Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasmEmmanuelle Verger, Isabelle Crassard, Bruno Cassinat, et al.
The Indian Journal of Medical Research|November 18, 2011
Pathophysiological insights in sickle cell diseaseMarie-Hélène Odièvre, Emmanuelle Verger, Ana Cristina Silva-Pinto, et al.
British Journal of Haematology|January 18, 2014
TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosisEmmanuelle Verger, Annalisa Andreoli, Christine Chomienne, et al.
Journal of Proteome Research|January 7, 2006
Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical RegionJoo-Ho Shin, Talin Gulesserian, Emmanuelle Verger, et al.
Clinical Hemorheology and Microcirculation|September 5, 2013
Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cellsEmmanuelle Verger, Damien Schoëvaërt, Pascal Carrivain, et al.
Leukemia & Lymphoma|August 27, 2016
Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN cloneEmmanuelle Verger, Ekarat Rattarittamrong, Gil Letort, et al.
British Journal of Haematology|November 17, 2015
Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutationEmmanuelle Verger, France Teillet, Carole Conejero, et al.
Haematologica|May 17, 2020
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patientsBruno Cassinat, Emmanuelle Verger, Nabih Maslah, et al.
International Journal of Laboratory Hematology|July 3, 2020
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patientsEmmanuelle Verger, Nabih Maslah, Marie-Helene Schlageter, et al.
Pageof 4